DICERNA Trademark

Trademark Overview

On Wednesday, May 16, 2018, a trademark application was filed for DICERNA with the United States Patent and Trademark Office. The USPTO has given the DICERNA trademark a serial number of 87924237. The federal status of this trademark filing is REGISTERED as of Tuesday, February 1, 2022. This trademark is owned by Dicerna Pharmaceuticals, Inc.. The DICERNA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
dicerna

General Information

Serial Number87924237
Word MarkDICERNA
Filing DateWednesday, May 16, 2018
Status700 - REGISTERED
Status DateTuesday, February 1, 2022
Registration Number6634061
Registration DateTuesday, February 1, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2018

Trademark Statements

Goods and ServicesResearch and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 24, 2018
Primary Code042
First Use Anywhere DateWednesday, November 14, 2007
First Use In Commerce DateWednesday, November 14, 2007

Trademark Owner History

Party NameDicerna Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameDicerna Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameDicerna Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Tuesday, February 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 1, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, January 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 28, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 27, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 21, 2021STATEMENT OF USE PROCESSING COMPLETE
Monday, December 13, 2021USE AMENDMENT FILED
Monday, December 13, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, June 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 5 GRANTED
Thursday, June 10, 2021SOU EXTENSION 5 FILED
Wednesday, June 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 10, 2021TEAS EXTENSION RECEIVED
Thursday, February 25, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 25, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2020SOU EXTENSION 4 GRANTED
Friday, December 11, 2020SOU EXTENSION 4 FILED
Friday, December 11, 2020TEAS EXTENSION RECEIVED
Friday, June 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 10, 2020SOU EXTENSION 3 GRANTED
Wednesday, June 10, 2020SOU EXTENSION 3 FILED
Wednesday, June 10, 2020TEAS EXTENSION RECEIVED
Friday, December 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 11, 2019SOU EXTENSION 2 GRANTED
Wednesday, December 11, 2019SOU EXTENSION 2 FILED
Wednesday, December 11, 2019TEAS EXTENSION RECEIVED
Wednesday, June 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2019SOU EXTENSION 1 GRANTED
Monday, June 10, 2019SOU EXTENSION 1 FILED
Monday, June 10, 2019TEAS EXTENSION RECEIVED
Monday, June 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 7, 2018ASSIGNED TO EXAMINER
Thursday, May 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 19, 2018NEW APPLICATION ENTERED

Related Keywords

dicerna research development diseases scientific disorders liver medical treatment oligonucleotide compounds